Literature DB >> 7579198

Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis.

G Trinchieri1.   

Abstract

Natural killer (NK) cells were originally defined by their ability to lyse tumor cells or virus-infected cells and identified as one type of effector cells of the non-antigen specific innate resistance. However, many recent studies have widened the interpretation of the role of NK cells in immunity and shown that NK cells have important regulatory roles in innate resistance, antigen-specific adaptive immunity, and, possibly, in hematopoiesis. These functions of NK cells more than on their cytotoxic activity, are probably dependent on their ability to produce lymphokines, particularly interferon-gamma (IFN-gamma). NK cells are important for antigen-independent activation of phagocytic cells early in infection and for favoring the development of antigen-specific T helper cells type I, producing IFN-gamma and IL-2. A role for NK cells in suppression of hematopoiesis and in induction of septic shock may represent a pathological exaggeration of the physiologic functions of NK cells in innate resistance.

Entities:  

Mesh:

Year:  1995        PMID: 7579198     DOI: 10.1006/smim.1995.0012

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  37 in total

1.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity.

Authors:  Jeffrey L Curtis; Antonello Punturieri
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05       Impact factor: 6.914

3.  Immunology: Close encounters of the second type.

Authors:  Gérard Eberl
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

4.  Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70.

Authors:  Ingrid Olsen; Preben Boysen; Siri Kulberg; Jayne C Hope; Gregers Jungersen; Anne K Storset
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Cloning of cDNAs with PDCD2(C) domain and their expressions during apoptosis of HEK293T cells.

Authors:  Qiu Chen; Kaixian Qian; Chengqi Yan
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

Review 6.  Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Authors:  A Reschner; P Hubert; P Delvenne; J Boniver; N Jacobs
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

7.  A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses.

Authors:  Amber Dunkel; Shixue Shen; Celia C LaBranche; David Montefiori; James P McGettigan
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-05       Impact factor: 2.205

8.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis.

Authors:  Min Chul Park; Taehee Kang; Da Jin; Jung Min Han; Sang Bum Kim; Yun Jung Park; Kiwon Cho; Young Woo Park; Min Guo; Weiwei He; Xiang-Lei Yang; Paul Schimmel; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

10.  Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.

Authors:  L Matera; E Beltramo; E Martinuzzi; S Buttiglieri
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.